Patent Application
Utility
PCT National Stage
App. No. 19/581,758
· Confirmation No. 3942
INFIGRATINIB AND METABOLITES THEREOF FOR USE IN METHODS OF TREATING SKELETAL DISORDERS
Applicant:
QED Therapeutics, Inc.
Application Undergoing Preexam Processing
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2026-04-24 | A.PE |
Preliminary Amendment | — | View | |
| 2026-04-24 | A.PE |
Preliminary Amendment | 1 | View | |
| 2026-04-24 | SPEC |
Specification | 1 | View | |
| 2026-04-24 | REM |
Applicant Arguments/Remarks Made in an Amendment | 1 | View | |
| 2026-04-24 | TRNA |
Transmittal of New Application | 4 | View | |
| 2026-04-24 | ADS |
Application Data Sheet | 9 | View | |
| 2026-04-24 | 371P |
Documents submitted with 371 (National Stage) Applications | 168 | View | |
| 2026-04-24 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2026-04-24 | N417.PYMT |
Electronic Fee Payment | 2 | View | |
| 2026-04-24 | P.N.101.CONV |
PCT/RO/101 - Request form for new International Application - Conventional | 1 | View | |
| 2026-04-24 | P.N.101.CONV |
PCT/RO/101 - Request form for new International Application - Conventional | 4 | View | |
| 2026-04-24 | FRPR |
Certified Copy of Foreign Priority Application | 186 | View | |
| 2026-04-24 | ABST |
Abstract | 1 | View | |
| 2026-04-24 | SPEC |
Specification | 136 | View | |
| 2026-04-24 | CLM |
Claims | 15 | View | |
| 2026-04-24 | DRW |
Drawings-only black and white line drawings | 12 | View |
Inventors
Attorneys & Agents of Record
Prosecution
- Customer No.
- 51414
- Docket No.
- QED-009USWO
- Confirmation No.
- 3942
No recorded assignments were found for this patent.
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 19/581,758
- Effective Filing
- 2026-04-24
External Links